$WMT just posted its slowest U.S. comparable sales growth in six years, and shares are down nearly 10%. Walmart beat on earnings and revenue, but a 125 basis point drag from pharmacy deflation tied to new Medicare Maximum Fair Price rules pulled the print to just 2.6%, the weakest quarterly comp since 2020. Q3 guidance also came in below Wall Street's estimate at $0.62-$0.64 vs $0.68. Here is what the numbers really say about Walmart, and about the American consumer. #Walmart #Earnings #RetailStocks 🌐 Find more market-moving insights at benzinga.com — your one-stop destination for the latest financial news, data, and expert analysis to stay ahead of the markets. 🖥️ Want the same tools the pros use—without the $10K Bloomberg terminal? Benzinga Edge gives you real-time portfolio alerts, weekly stock picks, and pro-grade research in one command center. 👉 bit.ly/4unSKiB ------------------------------------------------------------------------------------ 📲 Follo...